MELA Sciences Inc Share Price Nasdaq
Equities
US55277R3084
Advanced Medical Equipment & Technology
Sales 2024 * | 31.16M 2.6B | Sales 2025 * | 33.82M 2.83B | Capitalization | 10.31M 861M |
---|---|---|---|---|---|
Net income 2024 * | -10M -835M | Net income 2025 * | -5M -418M | EV / Sales 2024 * | 0.33 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.3 x |
P/E ratio 2024 * |
-1.05
x | P/E ratio 2025 * |
-1.9
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 58.9% |
Latest transcript on MELA Sciences Inc
Managers | Title | Age | Since |
---|---|---|---|
Dolev Rafaeli
CEO | Chief Executive Officer | 60 | 10/18/10 |
Director of Finance/CFO | 42 | 06/21/06 | |
Shmuel Gov
COO | Chief Operating Officer | - | 01/15/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Patricia Walker
BRD | Director/Board Member | 64 | 14/22/14 |
Uri Geiger
CHM | Chairman | 56 | 29/18/29 |
Homi Shamir
BRD | Director/Board Member | 70 | - |
1st Jan change | Capi. | |
---|---|---|
+8.50% | 220B | |
+24.13% | 149B | |
+33.45% | 113B | |
+3.95% | 65.75B | |
+14.10% | 52.43B | |
+4.08% | 50.47B | |
-4.98% | 38.54B | |
-3.34% | 34.12B | |
+22.18% | 30.87B |